MedPath

ImmusanT, Inc.

ImmusanT, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2011-06-08
Employees
1
Market Cap
-
Website
http://www.immusant.com

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)

Phase 2
Conditions
Celiac
Malabsorption Syndromes
Celiac Disease
Autoimmune Diseases
Intestinal Disease
Gastrointestinal Disease
Digestive System Disease
Gluten Sensitivity
First Posted Date
2018-08-23
Last Posted Date
2019-03-19
Lead Sponsor
ImmusanT, Inc.
Target Recruit Count
146
Registration Number
NCT03644069
Locations
🇺🇸

Diablo Clinical Research, Walnut Creek, California, United States

🇺🇸

Stamford Therapeutics Consortium, Stamford, Connecticut, United States

🇺🇸

Alliance Medical Research, Lighthouse Point, Florida, United States

and more 37 locations

Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease

Phase 1
Completed
Conditions
Gastrointestinal Disease
Digestive System Diseases
Celiac Disease
Intestinal Disease
Gluten Sensitivity
Coeliac Disease
Malabsorption Syndromes
Metabolic Disease
First Posted Date
2018-06-01
Last Posted Date
2018-09-20
Lead Sponsor
ImmusanT, Inc.
Target Recruit Count
14
Registration Number
NCT03543540
Locations
🇦🇺

Qpharm Pty Ltd, Herston, Queensland, Australia

🇦🇺

University of the Sunshine Coast, Sippy Downs, Queensland, Australia

🇦🇺

Linear Clinical Research, Nedlands, Western Australia, Australia

Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease

Phase 1
Completed
Conditions
Celiac Disease
First Posted Date
2015-08-19
Last Posted Date
2018-12-24
Lead Sponsor
ImmusanT, Inc.
Target Recruit Count
38
Registration Number
NCT02528799
Locations
🇦🇺

Q-Pharm Pty Ltd., Herston, Queensland, Australia

🇦🇺

CMAX, A Division of IDT Australia Ltd, Adelaide, South Australia, Australia

🇦🇺

Linear Clinical Research, Nedlands, Australia

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.